Teratocarcinoma-Derived Growth Factor 1 (TDGF1) (Internal Region) Peptid
TDGF1
Reaktivität: Human
Wirt: Synthetic
BP, BI
-
- Target Alle TDGF1 Produkte
- TDGF1 (Teratocarcinoma-Derived Growth Factor 1 (TDGF1))
- Protein-Typ
- Synthetic
- Protein Region
- Internal Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), BioImaging (BI)
- Produktmerkmale
- CRIPTO peptide is a synthetic peptide cooresponding to 13 amino acids from an internal region of CRIPTO.
-
-
- Applikationshinweise
- CRIPTO Peptide is used for blocking the activity of CRIPTO antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- CRIPTO peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 ?L water, the concentration will be 0.5 mg/mL.
- Handhabung
- When reconstituted minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C.
-
- Target
- TDGF1 (Teratocarcinoma-Derived Growth Factor 1 (TDGF1))
- Synonyme
- CR Peptide, CRGF Peptide, CRIPTO Peptide, CR1 Peptide, cripto Peptide, cb85 Peptide, tdgf1 Peptide, wu:fe01d04 Peptide, zgc:109829 Peptide, Cripto-1 Peptide, cr1 Peptide, cr1a Peptide, frl-1 Peptide, frl1 Peptide, xcr1 Peptide, TDGF1 Peptide, tdgf3 Peptide, cripto-3 Peptide, teratocarcinoma-derived growth factor 1 Peptide, teratocarcinoma-derived growth factor 1, member 3 L homeolog Peptide, teratocarcinoma-derived growth factor 1, member 1 Peptide, TDGF1 Peptide, Tdgf1 Peptide, tdgf1 Peptide, tdgf1.3.L Peptide, tdgf1.1 Peptide
- Gen-ID
- 6997
- NCBI Accession
- NP_005682, NP_064693
- UniProt
- P13385
-
Sie sind hier:
